Correlation of thyroid-stimulating hormone level with obesity in patients of polycystic ovary syndrome

Amrita Saha; Shashi Shukla; Preeti; Divya

doi:10.18203/2320-1770.ijrcog20242074

Authors

Amrita Saha Department of Obstetrics and Gynaecology, Dr Bheemrao Ramji Ambedkar Government Medical College, Kannauj, Atal Bihari Vajpayee Medical University, Lucknow, Uttar Pradesh, India
Shashi Shukla Department of Obstetrics and Gynaecology, Dr Bheemrao Ramji Ambedkar Government Medical College, Kannauj, Atal Bihari Vajpayee Medical University, Lucknow, Uttar Pradesh, India
Preeti Department of Obstetrics and Gynaecology, AIIMS, Raibareily, Uttar Pradesh, India
Divya Department of Obstetrics and Gynaecology, District Women Hospital, Mathura, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20242074

Keywords:

PCOS, Obesity, TSH

Abstract

Background: Polycystic ovarian syndrome (PCOS), a heterogeneous endocrine disorder is most common in women of the reproductive age group. Thyroid disorders and PCOS are two of the most common endocrine disorders in women. Although the etiopathogenesis of hypothyroidism and PCOS is completely different, these two disorders have many common features. An increase in ovarian volume and cystic changes in ovaries have been reported in primary hypothyroidism. The aim of this study was to find the correlation of thyroid-stimulating hormone (TSH) level in obese and non-obese women, who were diagnosed to have PCOS.

Methods: The data of 161 women who visited the institution for diagnosis and management of PCOS were included in the study. Demographic data like age, height and weight of the women at the time of diagnosis of PCOS were collected and subjected to analysis.

Results: The results showed that 15% obese PCOS women had high TSH level and 7% non- obese PCOS had high TSH level.

Conclusions: The result of the study suggests that higher level of TSH seen in obese PCOS women than non -obese PCOS women.

Metrics

Metrics Loading ...

References

Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. The Lancet. 2007;370(9588):685-97.

El Hayek S, Bitar L, Hamdar LH, Mirza FG, Daoud G. Poly Cystic Ovarian Syndrome: An Updated Overview. Front Physiol. 2016;7:124.

Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774 800.

Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165 9.

Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev. 2010;31:702 55.

Seppel T, Kosel A, Schlaghecke R. Bioelectric impedance assessment of body composition in thyroid disease. Eur J Endocrinol. 1997;136:493 8.

Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-7.

Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK. Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metab. 2013;17:304-9.

Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update. 2012;18:618-37.

Muscogiuri G, Sorice GP, Mezza T, Prioletta A, Lassandro AP, Pirronti T, et al. High-normal TSH values in obesity: Is it insulin resistance or adipose tissue's guilt? Obesity (Silver Spring). 2013;21:101-6.

Duntas LH, Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: The multifold role of leptin. Thyroid. 2013;23:646-53.

Singla R, Gupta Y, Khemani M, Aggarwal S. Thyroid disorders and polycystic ovary syndrome: An emerging relationship. Indian J Endocrinol Metab. 2015;19(1):25-9.

Ghosh S, Kabir SN, Pakrashi A, Chatterjee S, Chakravarty B. Subclinical hypothyroidism: a determinant of polycystic ovary syndrome. Horm Res. 1993;39(1-2):61-6.

Janssen OE, Mehlmauer N, Hahn S, Offner AH, Gärtner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol. 2004;150:363 9.

Dewailly D, Hieronimus S, Mirakian P, Hugues JN. Polycystic ovary syndrome (PCOS). Ann Endocrinol (Paris). 2010;71:8 13.

Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440 7.

Kinjo Y, Takasu N, Komiya I, Tomoyose T, Takara M, Kouki T, et al. Remission of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene. J Clin Endocrinol Metab. 2002;87(6):2593-6.

Barber TM, McCarthy MI, Wass JA, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrinol (Oxf). 2006;65:137-45.

Ollila MM, Piltonen T, Puukka K, Ruokonen A, Järvelin MR, Tapanainen JS, et al. Weight Gain and Dyslipidemia in Early Adulthood Associate With Polycystic Ovary Syndrome: Prospective Cohort Study. J Clin Endocrinol Metab. 2016;101(2):739-47.

Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, et al. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;36(1):105-11.

Shanmugham D, Natarajan S, Karthik A. Prevalence of thyroid dysfunction in patients with polycystic ovarian syndrome: a cross sectional study. Int J Reprod Contracept Obstet Gynecol. 2018;7(8):3055.

Najem F, Elmehdawi R, Swalem A. Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi Libya; A Retrospective study. Libyan J Med. 2008;3:71-4.

Enzevaei A, Salehpour S, Tohidi M, Saharkhiz N. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship? Iran J Reprod Med. 2014;12(7):481-6.

Sinha U, Sinharay K, Saha S, Longkumer TA, Baul SN, Pal SK. Thyroid disorders in polycystic ovarian syndrome subjects: A tertiary hospital based cross-sectional study from Eastern India. Indian J Endocrinol Metab. 2013;17(2):304-9.

Ding X, Yang L, Wang J, Tang R, Chen Q, Pan J, et al. Subclinical Hypothyroidism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2018;9:700.